Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study~of~Heart~and Renal Protection (SHARP)

Borislava Mihaylova, Iryna Schlackow, William Herrington, Jingky Lozano-Kühne, Seamus Kent, Jonathan Emberson, Christina Reith, Richard Haynes, Alan Cass, Jonathan Craig, Alastair Gray, Rory Collins, Martin J. Landray, Colin Baigent, R. Collins, C. Baigent, M. J. Landray, C. Bray, Y. Chen, A. Baxter, A. Young, M. Hill, C. Knott, A. Cass, B. Feldt-Rasmussen, B. Fellström, D. E. Grobbee, C. Grönhagen-Riska, M. Haas, H. Holdaas, L. S. Hooi, L. Jiang, B. Kasiske, U. Krairittichai, A. Levin, Z. A. Massy, V. Tesar, R. Walker, C. Wanner, D. C. Wheeler, A. Wiecek, T. Dasgupta, W. Herrington, D. Lewis, M. Mafham, W. Majoni, C. Reith, J. Emberson, S. Parish, D. Simpson, J. Strony, T. Musliner, L. Agodoa, J. Armitage, Z. Chen, J. Craig, D. de Zeeuw, J. M. Gaziano, R. Grimm, V. Krane, B. Neal, V. Ophascharoensuk, T. Pedersen, P. Sleight, J. Tobert, C. Tomson
April 2016
Cite DOI URL
Type
Journal article
Publication
American Journal of Kidney Diseases
Lozano-Kuehne

Related